Re: Blocking oncogenic Ras signaling for cancer therapy.
Canevari
Silvana
S
Biocca
Silvia
S
Figini
Mariangela
M
D019883:Alkyl and Aryl Transferases / Q000037:antagonists & inhibitors; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002453:Cell Cycle; D002455:Cell Division; D011905:Genes, ras / Q000187:drug effects*; D015316:Genetic Therapy; D006801:Humans; D009154:Mutation / Q000187:drug effects; D009369:Neoplasms / Q000235:genetics / Q000628:therapy*; D016376:Oligonucleotides, Antisense / Q000494:pharmacology; D017368:Protein Prenylation; D015398:Signal Transduction / Q000187:drug effects*; D018631:ras Proteins / Q000187:drug effects / Q000235:genetics*
D000970:Antineoplastic Agents; D016376:Oligonucleotides, Antisense; D019883:Alkyl and Aryl Transferases; C083291:geranylgeranyltransferase type-I; C064911:p21(ras) farnesyl-protein transferase; D018631:ras Proteins